0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 21-40 of 215 Articles
Original Investigation | 
Kenneth K. Mugwanya, MBChB, MS; Christina Wyatt, MD, MS; Connie Celum, MD, MPH; et al.
JAMA Intern Med. 2015;175(2):246-254. doi:10.1001/jamainternmed.2014.6786.
Includes: Supplemental Content

Original Investigation | 
Inmaculada Hernandez, PharmD; Seo Hyon Baik, PhD; Antonio Piñera, MD; et al.
JAMA Intern Med. 2015;175(1):18-24. doi:10.1001/jamainternmed.2014.5398.
Includes: CME, Supplemental Content

Special Communication | 
Daniel J. Morgan, MD, MS; Scott M. Wright, MD; Sanket Dhruva, MD
JAMA Intern Med. 2015;175(1):120-124. doi:10.1001/jamainternmed.2014.5444.
Includes: Supplemental Content

Research Letter | 
Michael D. Miedema, MD, MPH; Faye L. Lopez, MS, MPH; Michael J. Blaha, MD, MPH; et al.
JAMA Intern Med. 2015;175(1):138-140. doi:10.1001/jamainternmed.2014.6288.

Original Investigation | 
Meera Viswanathan, PhD; Leila C. Kahwati, MD, MPH; Carol E. Golin, MD; et al.
JAMA Intern Med. 2015;175(1):76-87. doi:10.1001/jamainternmed.2014.5841.
Includes: Supplemental Content

Invited Commentary | 
Joshua J. Gagne, PharmD, ScD
JAMA Intern Med. 2014;174(12):1934-1935. doi:10.1001/jamainternmed.2014.3270.

Invited Commentary | 
Howard D. Weiss, MD; Gregory M. Pontone, MD
JAMA Intern Med. 2014;174(12):1935-1937. doi:10.1001/jamainternmed.2014.4097.

Original Investigation | 
Thomas J. Moore, AB; Joseph Glenmullen, MD; Donald R. Mattison, MD, MS
JAMA Intern Med. 2014;174(12):1930-1933. doi:10.1001/jamainternmed.2014.5262.

Perspective | 
Jonathan McDonagh
JAMA Intern Med. 2014;174(12):1889. doi:10.1001/jamainternmed.2014.5376.

Perspective | 
Vinod E. Nambudiri, MD, MBA
JAMA Intern Med. 2014;174(11):1724-1725. doi:10.1001/jamainternmed.2014.4026.

Research Letter | 
Gudrun Jonasdottir Bergman, PhD; Staffan Khan; Bengt Danielsson, MD, PhD; et al.
JAMA Intern Med. 2014;174(10):1700-1701. doi:10.1001/jamainternmed.2014.3867.

Case Report/Case Series | 
Evangelia Liakoni, MD; Alexandra E. Rätz Bravo, PhD; Luigi Terracciano, MD; et al.
JAMA Intern Med. 2014;174(10):1683-1686. doi:10.1001/jamainternmed.2014.3912.

Invited Commentary | 
Kasia J. Lipska, MD, MHS
JAMA Intern Med. 2014;174(10):1612-1613. doi:10.1001/jamainternmed.2014.3290.

Perspective | 
Kenneth W. Hung, MD; Judith Blaine, MD, PhD; Sarah Faubel, MD
JAMA Intern Med. 2014;174(9):1429-1430. doi:10.1001/jamainternmed.2014.3460.

Research Letter | 
German Morís, MD; Juan Carlos Garcia-Monco, MD
JAMA Intern Med. 2014;174(9):1511-1512. doi:10.1001/jamainternmed.2014.2918.

Invited Commentary | 
Wayne B. Jonas, MD, LTC (Ret); Eric B. Schoomaker, MD, PhD, LTG (Ret)
JAMA Intern Med. 2014;174(8):1402-1403. doi:10.1001/jamainternmed.2014.2114.

Invited Commentary | 
Beatrice Alexandra Golomb, MD, PhD
JAMA Intern Med. 2014;174(8):1270-1272. doi:10.1001/jamainternmed.2013.14543.

Original Investigation |  FREE
David S. H. Lee, PharmD, PhD; Sheila Markwardt, BS; Leah Goeres, PharmD; et al.
JAMA Intern Med. 2014;174(8):1263-1270. doi:10.1001/jamainternmed.2014.2266.

Perspective | 
Avery MacKenzie, MD
JAMA Intern Med. 2014;174(8):1221-1222. doi:10.1001/jamainternmed.2014.2124.

Invited Commentary | 
David M. Shahian, MD
JAMA Intern Med. 2014;174(8):1328-1329. doi:10.1001/jamainternmed.2014.155.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Otolaryngology–Head & Neck Surgery
Original Investigation  | 
Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy
Eleonoor A. R. Theunissen, MD; Charlotte L. Zuur, MD, PhD; Katarzyna Jóźwiak, PhD; et al.
JAMA Ophthalmology
Original Investigation  | 
Association of Compounded Bevacizumab With Postinjection Endophthalmitis
Brian L. VanderBeek, MD, MPH; Sarah G. Bonaffini, BS; Liyuan Ma, MS
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Oncology
Invited Commentary  | 
PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events
Benjamin Movsas, MD